These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 28363474)
1. Disparity between pre-existing management of penile cancer and NCCN guidelines. Campbell RA; Slopnick EA; Ferry EK; Zhu H; Kim SP; Abouassaly R Urol Oncol; 2017 Aug; 35(8):531.e9-531.e14. PubMed ID: 28363474 [TBL] [Abstract][Full Text] [Related]
2. Treatment Trends and Outcomes for Patients With Lymph Node-Positive Cancer of the Penis. Joshi SS; Handorf E; Strauss D; Correa AF; Kutikov A; Chen DYT; Viterbo R; Greenberg RE; Uzzo RG; Smaldone MC; Geynisman DM JAMA Oncol; 2018 May; 4(5):643-649. PubMed ID: 29494739 [TBL] [Abstract][Full Text] [Related]
3. Disease-specific survival after radical lymphadenectomy for penile cancer: prediction by lymph node count and density. Li ZS; Yao K; Chen P; Zou ZJ; Qin ZK; Liu ZW; Li YH; Zhou FJ; Han H Urol Oncol; 2014 Aug; 32(6):893-900. PubMed ID: 24994488 [TBL] [Abstract][Full Text] [Related]
4. Clear-cell differentiation and lymphatic invasion, but not the revised TNM classification, predict lymph node metastases in pT1 penile cancer: a clinicopathologic study of 76 patients from a low incidence area. Mannweiler S; Sygulla S; Tsybrovskyy O; Razmara Y; Pummer K; Regauer S Urol Oncol; 2013 Oct; 31(7):1378-85. PubMed ID: 22421354 [TBL] [Abstract][Full Text] [Related]
5. Population-based assessment of the number of lymph nodes removed in the treatment of penile squamous cell carcinoma. Zhu Y; Gu CY; Ye DW Urol Int; 2014; 92(2):186-93. PubMed ID: 24246932 [TBL] [Abstract][Full Text] [Related]
6. Contemporary management of regional nodes in penile cancer-improvement of survival? Djajadiningrat RS; Graafland NM; van Werkhoven E; Meinhardt W; Bex A; van der Poel HG; van Boven HH; Valdés Olmos RA; Horenblas S J Urol; 2014 Jan; 191(1):68-73. PubMed ID: 23917166 [TBL] [Abstract][Full Text] [Related]
7. Lymph node metastasis in intermediate-risk penile squamous cell cancer: a two-centre experience. Hughes BE; Leijte JA; Kroon BK; Shabbir MA; Swallow TW; Heenan SD; Corbishley CM; van Boven HH; Perry MJ; Watkin NA; Horenblas S Eur Urol; 2010 Apr; 57(4):688-92. PubMed ID: 19647926 [TBL] [Abstract][Full Text] [Related]
8. [Diagnosis and therapy for penile cancer: a report of 46 cases with literature review]. Zheng FF; Liang YY; Guo YS; Dai YP; Zheng KL Ai Zheng; 2008 Sep; 27(9):962-5. PubMed ID: 18799036 [TBL] [Abstract][Full Text] [Related]
9. Management of the lymph nodes in penile cancer. Heyns CF; Fleshner N; Sangar V; Schlenker B; Yuvaraja TB; van Poppel H Urology; 2010 Aug; 76(2 Suppl 1):S43-57. PubMed ID: 20691885 [TBL] [Abstract][Full Text] [Related]
10. Swedish National Penile Cancer Register: incidence, tumour characteristics, management and survival. Kirrander P; Sherif A; Friedrich B; Lambe M; Håkansson U; BJU Int; 2016 Feb; 117(2):287-92. PubMed ID: 25395083 [TBL] [Abstract][Full Text] [Related]
12. Lessons learnt in the management of primary invasive penile cancer in an Australian tertiary referral centre: clinical outcomes with a minimum 48 months follow-up study. Chung E; Yang S; White L; Wood S; Nicol D Korean J Urol; 2015 Feb; 56(2):125-30. PubMed ID: 25685299 [TBL] [Abstract][Full Text] [Related]
13. Natural history, management, and surveillance of recurrent squamous cell penile carcinoma: a risk-based approach. Sánchez-Ortiz RF; Pettaway CA Urol Clin North Am; 2003 Nov; 30(4):853-67. PubMed ID: 14680320 [TBL] [Abstract][Full Text] [Related]
14. Reliability of radioisotope-guided sentinel lymph node biopsy in penile cancer: verification in consideration of the European guidelines. Schubert T; Uphoff J; Henke RP; Wawroschek F; Winter A BMC Urol; 2015 Sep; 15():98. PubMed ID: 26416391 [TBL] [Abstract][Full Text] [Related]
15. Adherence to guideline recommendations for lymph node dissection in squamous cell carcinoma of the penis: Effect on survival and complication rates. Mistretta FA; Mazzone E; Palumbo C; Knipper S; Tian Z; Nazzani S; Tilki D; Musi G; Perrotte P; Montanari E; Shariat SF; Saad F; Briganti A; de Cobelli O; Karakiewicz PI Urol Oncol; 2019 Sep; 37(9):578.e11-578.e19. PubMed ID: 31296420 [TBL] [Abstract][Full Text] [Related]
16. Patterns of Regional Lymphadenectomy for Clinically Node-negative Patients With Penile Carcinoma: Analysis From the National Cancer Database From 1998 to 2012. Chipollini J; Tang DH; Sharma P; Baumgarten AS; Spiess PE Clin Genitourin Cancer; 2017 Dec; 15(6):670-677.e1. PubMed ID: 28522287 [TBL] [Abstract][Full Text] [Related]
17. A 10-year retrospective audit of penile cancer management in the UK. Mistry T; Jones RW; Dannatt E; Prasad KK; Stockdale AD BJU Int; 2007 Dec; 100(6):1277-81. PubMed ID: 17850372 [TBL] [Abstract][Full Text] [Related]
18. Tumor stage, vascular invasion and the percentage of poorly differentiated cancer: independent prognosticators for inguinal lymph node metastasis in penile squamous cancer. Slaton JW; Morgenstern N; Levy DA; Santos MW; Tamboli P; Ro JY; Ayala AG; Pettaway CA J Urol; 2001 Apr; 165(4):1138-42. PubMed ID: 11257655 [TBL] [Abstract][Full Text] [Related]
19. Lymph-node metastases in intermediate-risk squamous cell carcinoma of the penis. Naumann CM; Alkatout I; Al-Najar A; Korda JB; Hegele A; Bolenz C; Ziegler H; Klöppel G; Juenemann KP; van der Horst C BJU Int; 2008 Nov; 102(9):1102-6. PubMed ID: 18489528 [TBL] [Abstract][Full Text] [Related]
20. Contemporary management of penile cancer including surgery and adjuvant radiotherapy: an experience in Taiwan. Chen MF; Chen WC; Wu CT; Chuang CK; Ng KF; Chang JT World J Urol; 2004 Apr; 22(1):60-6. PubMed ID: 14657999 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]